Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

Completed

• Conditions: Acquired Haemophilia; Register

• Registration Number: NCT00213473
• Lead Sponsor: University Hospital, Rouen

Brief Summary

the aims of SACHA study was to appreciate prevalence, evolution and follow-up, treatment response of patients with acquired hemophilia with biological and clinical data. Inclusion criteria were factor VIIIc below 30% associated with presence of Facgteur VIII inhibitor (titer \> 1 u Bethesda. Clinical and biologival data were obtained at Day 0 (as soon as possible and at 1, 3, 6 and 12 months.Informations were notified to co-investigators with the help of two french medical society (Internal medicine, french haemostasis and thrombosis society.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-06
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Study Completion: 2006-05
• Status Verified: 2013-06
• Last Update Submitted: 2013-06-17
• Last Update Posted: 2013-06-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 81

Inclusion Criteria

• Factor VIIIc < 30% and Factor VIII inhibitor > 1 u Bethesda

Exclusion Criteria

• absence and signed consent, haemophilia A

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

University Hospital of Rouen; 🇫🇷 Rouen, France